These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 23320610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R, Watanabe JH, Bounthavong M.
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of copayment and statin adherence stratified by socioeconomic status.
    Kazerooni R, Bounthavong M, Watanabe JH.
    Ann Pharmacother; 2013 Nov; 47(11):1463-70. PubMed ID: 24259605
    [Abstract] [Full Text] [Related]

  • 5. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.
    Pittman DG, Chen W, Bowlin SJ, Foody JM.
    Am J Cardiol; 2011 Jun 01; 107(11):1662-6. PubMed ID: 21439533
    [Abstract] [Full Text] [Related]

  • 6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.
    Pharmacotherapy; 2012 Jul 01; 32(7):631-41. PubMed ID: 22760692
    [Abstract] [Full Text] [Related]

  • 8. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X, Gross CR, Schommer J, Cline R, St Peter WL.
    Clin Ther; 2007 Dec 01; 29(12):2748-57. PubMed ID: 18201593
    [Abstract] [Full Text] [Related]

  • 9. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
    Watanabe JH, Kazerooni R, Bounthavong M.
    J Manag Care Pharm; 2014 Jan 01; 20(1):43-50. PubMed ID: 24372459
    [Abstract] [Full Text] [Related]

  • 10. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population.
    Burton WN, Chen CY, Schultz AB, Edington DW.
    Popul Health Manag; 2010 Feb 01; 13(1):1-8. PubMed ID: 20158317
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.
    Kim HJ, Kim E, Min KB, Min JY.
    Curr Med Res Opin; 2017 Feb 01; 33(2):385-390. PubMed ID: 27819152
    [Abstract] [Full Text] [Related]

  • 12. Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade?
    Vodonos A, Ostapenko I, Toledano R, Henkin Y, Zahger D, Wolak T, Sherf M, Novack V.
    Eur J Intern Med; 2015 May 01; 26(4):268-72. PubMed ID: 25770073
    [Abstract] [Full Text] [Related]

  • 13. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L, Buysschaert M, Hermans MP.
    J Clin Lipidol; 2012 May 01; 6(5):434-42. PubMed ID: 23009779
    [Abstract] [Full Text] [Related]

  • 14. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
    Marrs JC, Saseen JJ.
    Pharmacotherapy; 2008 May 01; 28(5):562-9. PubMed ID: 18447654
    [Abstract] [Full Text] [Related]

  • 15. The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate.
    Oleen-Burkey MA, Dor A, Castelli-Haley J, Lage MJ.
    J Med Econ; 2011 May 01; 14(6):739-47. PubMed ID: 21913796
    [Abstract] [Full Text] [Related]

  • 16. Adherence to statins and LDL-cholesterol goal attainment.
    Chi MD, Vansomphone SS, Liu IL, Cheetham C, Green KR, Scott RD, Reynolds K.
    Am J Manag Care; 2014 Apr 01; 20(4):e105-12. PubMed ID: 24884955
    [Abstract] [Full Text] [Related]

  • 17. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.
    Clin Ther; 2007 Nov 01; 29(11):2385-94. PubMed ID: 18158079
    [Abstract] [Full Text] [Related]

  • 18. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 01; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 01; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 20. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.
    Expert Opin Pharmacother; 2008 Apr 01; 9(5):669-76. PubMed ID: 18345946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.